Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTS,S/AS01E infant EPI schedule safety and immunogenicity study
2012-005695-34Phase 2
- Sponsor
- GSK
- Start
- Jun 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of RTS,S in Falciparum malaria (PF), sponsored by GSK.
02
Drugs
RTS,S
03
Conditions
Falciparum malaria (PF)
Beyond the preview
Go deeper on 2012-005695-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005695-34.